Entrada Therapeutics (TRDA) Change in Acquisitions & Divestments: 2022-2025
Historic Change in Acquisitions & Divestments for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $75.5 million.
- Entrada Therapeutics' Change in Acquisitions & Divestments fell 9.36% to $75.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.6 million, marking a year-over-year decrease of 18.00%. This contributed to the annual value of $413.1 million for FY2024, which is 50.52% up from last year.
- As of Q3 2025, Entrada Therapeutics' Change in Acquisitions & Divestments stood at $75.5 million, which was up 49.14% from $50.6 million recorded in Q2 2025.
- Over the past 5 years, Entrada Therapeutics' Change in Acquisitions & Divestments peaked at $123.9 million during Q1 2024, and registered a low of $1.7 million during Q1 2022.
- Its 3-year average for Change in Acquisitions & Divestments is $81.8 million, with a median of $83.3 million in 2024.
- As far as peak fluctuations go, Entrada Therapeutics' Change in Acquisitions & Divestments surged by 3,575.61% in 2023, and later slumped by 42.05% in 2025.
- Entrada Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $19.5 million in 2022, then soared by 456.62% to $108.5 million in 2023, then increased by 9.17% to $118.5 million in 2024, then declined by 9.36% to $75.5 million in 2025.
- Its last three reported values are $75.5 million in Q3 2025, $50.6 million for Q2 2025, and $85.9 million during Q1 2025.